Thus, it is speculated that the effect of HMGB1 on CAM phenotype switching through AC inhibition contributes to the pathogenesis of vasculopathy associated with metabolic disorders such as obesity and diabetes. This evidence concerns the gene HMGB1 and obesity due to melanocortin 4 receptor deficiency.